Skip to content

Neuronetics STIM Non-Controlling Interests

Non-Controlling Interests at other companies

Cabot Corporation logo
Cabot CorporationCBT
$119M-27.0%
Travel + Leisure logo
Travel + LeisureTNL
-$1M
Hyster-Yale Materials Handling, Inc. logo
Hyster-Yale Materials Handling, Inc.HY
$4.3M0.0%
Bioventus logo
BioventusBVS
$45.36M+21.5%
US Physical Therapy logo
US Physical TherapyUSPH
$459K-73.0%
Aebi Schmidt Holding AG Common Stock logo
Aebi Schmidt Holding AG Common StockAEBI
$26K-62.9%

Other financials

Income statement

See full
Revenue$34.5M+7.8%
Gross profit$16.2M+2.6%
Operating income-$9.0M+18.3%
Net income-$10.8M+14.9%
EPS (diluted)-$0.16+23.8%

Balance sheet

See full
Cash & equivalents$13.2M-34.7%
Total debt$85.4M+3.5%
Total equity$13.3M-62.6%
Total assets$125.4M-11.7%

Cash flow

See full
Operating cash flow-$9.4M+44.6%
CapEx$197.0K-10.0%
Free cash flow-$9.6M+44.1%

Valuation

See full
Market cap$90.46M-56.2%
Enterprise value$162.64M-42.0%
P/S0.6×-1.3×

Profitability

See full
Gross margin48%-15.6pp
Operating margin-19.4%-6.9pp
Net margin-24.5%-8.7pp
FCF margin-9.4%-4.1pp

Returns & leverage

See full
Return on equity-152.4%-1.4pp
Debt / equity6.4×+4.1×
Current ratio1.7×-0.8×

Where this comes from

Reported directly by Neuronetics in its filing.

Tagged under the XBRL concept us-gaap:MinorityInterest.

The official record: Neuronetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neuronetics's non-controlling interests.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Neuronetics's non-controlling interests?
Neuronetics (STIM) reported non-controlling interests of $3.8M in Q1 2026.
How has Neuronetics's non-controlling interests changed year-over-year?
Neuronetics's non-controlling interests decreased by 7.0% year-over-year, from $4.08M to $3.8M.
What does non-controlling interests mean?
Equity attributable to minority shareholders in subsidiaries not fully owned by the parent — their proportional claim on subsidiary net assets.